Indeed, recent work has identified that a variant in the regulatory region of a transcriptional repressor of IL-21, myocyte enhancer factor 2D (Mef2d), is associated with SLE (92, 93). This evidence concerns the gene MEF2D and systemic lupus erythematosus.